GENE ONLINE|News &
Opinion
Blog

RNAi
Funding Antisense RNA
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
Trials & Approvals RNAi
Alnylam Posts Positive Phase 2 Results for its RNAi Nephropathy Drug
2022-08-30
Trials & Approvals RNAi Therapeutics
FDA Approves Alnylam’s Rare Disease RNAi Therapeutic
2022-06-15
Deals RNAi
Arrowhead, Vivo Form Visirna to Take on China RNAi Market
2022-04-26
IPO Hong Kong
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
M&A RNA Therapeutics
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
China
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
Trials & Approvals RNAi
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Trials & Approvals Liver Enzyme
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
Funding RNAi Therapeutics
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
AATD
Takeda Collaborates with Arrowhead to Overcome Inherited Disorder via RNAi Therapy
2020-10-10
Trials & Approvals RNAi Therapeutics
Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
COVID-19 Antibody
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
Technology siRNA
RNA-Silencing Protein AGO4 Functions In Antiviral Defense
2020-02-14
In-Depth RNA Therapeutics
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
1 2
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top